SMAD3 and gastric cancer: Hypomethylated SMAD3 was found in cancers of the digestive system, such as liver cancer (8/12, 66.6%), gastric cancer (1/2, 50%), colon cancer (36/38, 94.7%), and rectal cancer (7/7, 100%) (Figure 7).